320 related articles for article (PubMed ID: 20730696)
1. The utility of cardiovascular drugs in the treatment of cerebrovascular disease.
Bösel J; Amiri H
Curr Opin Investig Drugs; 2010 Sep; 11(9):1015-24. PubMed ID: 20730696
[TBL] [Abstract][Full Text] [Related]
2. Does the preventive effect of different drugs depend on location of the atherosclerotic process?
Poredos P; Jezovnik MK
Int Angiol; 2008 Aug; 27(4):274-80. PubMed ID: 18677288
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of drug treatments for primary prevention of cardiovascular disease: a modelling study.
Marshall T
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):523-8. PubMed ID: 16874140
[TBL] [Abstract][Full Text] [Related]
4. Managing the risks of cardiac therapy in cancer patients.
Chen CL; Parameswaran R
Semin Oncol; 2013 Apr; 40(2):210-7. PubMed ID: 23540746
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological treatment of ischemic stroke.
Bentley P; Sharma P
Pharmacol Ther; 2005 Dec; 108(3):334-52. PubMed ID: 16135384
[TBL] [Abstract][Full Text] [Related]
6. Drug therapy of neurovascular disease.
Weinberger J; Frishman WH; Terashita D
Cardiol Rev; 2003; 11(3):122-46. PubMed ID: 12705843
[TBL] [Abstract][Full Text] [Related]
7. Re: Secondary medical prevention in patients with peripheral arterial disease.
Schouten O; Welten GM; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
[No Abstract] [Full Text] [Related]
8. Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease.
Blinc A; Poredos P
Eur J Clin Invest; 2007 Mar; 37(3):157-64. PubMed ID: 17359482
[TBL] [Abstract][Full Text] [Related]
9. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke.
Fletcher GF; Bufalino V; Costa F; Goldstein LB; Jones D; Smaha L; Smith SC; Stone N
Am J Cardiol; 2007 Mar; 99(6C):1E-35E. PubMed ID: 17378996
[No Abstract] [Full Text] [Related]
11. [Large trials in the secondary prevention of stroke].
Gensini GF; Simone I; Pantoni L; Inzitari D
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():102S-109S. PubMed ID: 9004808
[TBL] [Abstract][Full Text] [Related]
12. [Medical treatment of intracranial arterial stenosis. Are primary and secondary prevention the same thing?].
Irimia-Sieira P; Riverol-Fernández M; Martínez-Vila E
Rev Neurol; 2003 Oct 1-15; 37(7):644-8. PubMed ID: 14582022
[TBL] [Abstract][Full Text] [Related]
13. Changing chronobiology of cardiovascular outcome following prophylaxis.
Jose VM; Sharma N; Hota D; Pandhi P
Nepal Med Coll J; 2007 Mar; 9(1):1-5. PubMed ID: 17593669
[TBL] [Abstract][Full Text] [Related]
14. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
15. Drug treatment and cost of cardiovascular disease in Australia.
Ademi Z; Liew D; Chew D; Conner G; Shiel L; Nelson M; Soman A; Steg G; Bhatt DL; Reid C;
Cardiovasc Ther; 2009; 27(3):164-72. PubMed ID: 19689615
[TBL] [Abstract][Full Text] [Related]
16. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.
; ; ; ; ;
Heart; 2005 Dec; 91 Suppl 5(Suppl 5):v1-52. PubMed ID: 16365341
[No Abstract] [Full Text] [Related]
17. Risk stratification for the prevention of cardiovascular complications of hypertension.
Girerd X; Giral P
Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
[TBL] [Abstract][Full Text] [Related]
18. Stroke in China.
Jia Q; Liu LP; Wang YJ
Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):259-64. PubMed ID: 19769611
[TBL] [Abstract][Full Text] [Related]
19. Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy.
Tsang JL; Mendelsohn A; Tan MK; Hackam DG; Leiter LA; Fitchett D; Lin PJ; Grima E; Langer A; Goodman SG;
Am J Cardiol; 2008 Nov; 102(9):1142-5. PubMed ID: 18940280
[TBL] [Abstract][Full Text] [Related]
20. Statins in hypertension: are they a new class of antihypertensive agents?
Feldstein CA
Am J Ther; 2010; 17(3):255-62. PubMed ID: 19918164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
